Table 2.
Summary of percentage CD8+ IFNγ+ responses in SARS subject 1 induced by truncated peptides within M29 region. T cells used were obtained from SARS subject 1 at 9 years post-infection. Results of positive peptides (M29, M29144–155, M29145–155, M29146–155, M29147–155) and selected negative peptides (M29143–154, M29145–154, M29148–155) are shown. Percentage CD8+IFNγ+ T cells shown represents the percentage of IFNγ-producing CD8+ T cells in the total T cell population (after gating the CD3+ cells) present in the short-term T cell line obtained by restimulation using M29 peptide. The minimal epitope is indicated in italics.
Peptide | Peptide length | Amino acid position | Peptide sequence | Percentage of CD8+IFNγ+ T cells |
---|---|---|---|---|
M29 | 15-mer | 141–155 | AVIIR GHLRM AGHSL | 5.3% |
M29144–155 | 12-mer | 144–155 | IR GHLRM AGHSL | 14.8% |
M29143–154 | 12-mer | 143–154 | IIR GHLRM AGHS | 0.2% |
M29145–155 | 11-mer | 145–155 | R GHLRM AGHSL | 17.8% |
M29146–155 | 10-mer | 146–155 | GHLRM AGHSL | 22.8% |
M29145–154 | 10-mer | 145–154 | R GHLRM AGHS | 0.2% |
M29147–155 | 9-mer | 147–155 | HLRM AGHSL | 32.9% |
M29148–155 | 8-mer | 148–155 | LRM AGHSL | 0.3% |
Unstimulated cells | 0.2% | |||
PMA/Ionomycin-stimulated cells | 11.1% |